MABPHARM
Mabpharm is a biopharmaceutical company in China, specializing in the development and production of new drugs and biosimilars for the treatment of cancer and autoimmune diseases.They are committed to bringing high-quality and affordable innovative biopharmaceuticals to the market through their highly efficient R&D systems and low-cost pharmaceutical production capabilities, and to leverage their extensive R&D experience to develop a wide range of therapeutic products. Their Taizhou Pharmaceutic... al production base has two buildings, each covering 15,000 square meters, and is housed in their single antibody production facility. Currently, their drug candidate pipeline currently includes 9 monoclonal antibody drugs, 3 of which are core products in Phase III clinical trials: CMAB007 (Omazumab), CMAB009 (Cetuximab) and CMAB008 (Inflix Infliximab). In addition, their other two drug candidates, CMAB809 (trastuzumab) and CMAB819 (navumab), have been approved for clinical trials.
MABPHARM
Industry:
Pharmaceutical
Address:
Taizhou, Jiangsu, China
Country:
China
Website Url:
http://www.mabpharm.cn
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Font Awesome Apache Mobile Non Scaleable Content GoDaddy SSL Alibaba Matomo
Official Site Inspections
http://www.mabpharm.cn Semrush global rank: 6.76 M Semrush visits lastest month: 816
- Host name: 47.90.9.73
- IP address: 47.90.9.73
- Location: Hong Kong
- Latitude: 22.25
- Longitude: 114.1667
- Timezone: Asia/Hong_Kong
More informations about "Mabpharm"
邁博藥業有限公司 - mabpharm.cn
邁博藥業有限公司是中國領先的生物醫藥公司，專注於治療癌症和自身免疫性疾病的新藥及生物類似藥的研發和生產。 我們致力於透過我們高效的研發體系以及低成本藥品生產能力為市場帶 …See details»
迈博药业有限公司 - mabpharm.cn
迈博药业有限公司是中国领先的生物医药公司，专注于治疗癌症和自身免疫性疾病的新药及生物类似药的研发和生产。 我们致力于透过我们高效的研发体系以及低成本药品生产能力为市场带来高质量且可负担的创新型生物药品，并充分利用自 …See details»
Mabpharm Limitied
Mabpharm Limited is a leading biopharmaceutical company in China, focusing on the research, development and production of new drugs and biosimilar for cancers and autoimmune …See details»
Mabpharm - Crunchbase Company Profile & Funding
Mabpharm is a biopharmaceutical company in China, specializing in the development and production of new drugs and biosimilars for the treatment of cancer and autoimmune …See details»
Mabpharm Ltd. - CMOCRO - Domain Name
Mabpharm Limited is a biopharmaceutical company in China, focusing on the research, development and production of new drugs and biosimilar for cancers and autoimmune diseases.See details»
Mabpharm Ltd.
了解Mabpharm Ltd. (邁博藥業有限公司)公司的药物管线，治疗领域，技术平台，以及它的22项临床试验, 112篇新闻和7篇文献，疾病领域:免疫系统疾病，感染，肿瘤，血液及淋巴系统疾病， …See details»
Mabpharm Limitied
Mabpharm Limited is a leading biopharmaceutical company in China, focusing on the research, development and production of new drugs and biosimilar for cancers and autoimmune diseases.See details»
迈博药业-迈博药业有限公司-企业详情-InvestGO数据库-ByDrug-医 …
Aug 12, 2018 · 迈博药业（迈博药业有限公司），公司简介：迈博药业有限公司是中国领先的生物医药公司，专注于治疗癌症和自身免疫性疾病的新药及生物类似药的研发和生产。 我们致力 …See details»
Mabpharm Limited 迈博药业有限公司 - HKEXnews
請注意，所有未來公司通訊的英文版和中文版將在公司網站www.mabpharm.cn/tc/index.php 和香港聯合交易所有限公司網站 www.hkexnews.hk 上提供，以代替印刷本。 閣下需要主動查看公 …See details»
Mabpharm - Overview, News & Similar companies | ZoomInfo.com
View Mabpharm (www.mabpharm.cn) location in China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Mabpharm Ltd, 2181:HKG profile - FT.com - Financial Times
Nov 14, 2024 · Mabpharm Ltd (2181:HKG) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Mabpharm Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Dec 27, 2023 · UPB-101 is a monoclonal antibody designed to block the thymic stromal lymphopoietin receptor (TLSPR) and thus inhibit TSLP-driven inflammation. TSLP is a …See details»
Mabpharm Limitied
Dr. Wang Hao (“Dr. Wang”) was appointed as an Executive Director and Chief Scientist of the Company in August 2018, and was appointed as the Chief Executive Officer of the Company …See details»
Mabpharm Limited 邁博藥業有限公司 - HKEXnews
Mabpharm has established a product portfolio targeting allergic diseases, autoimmune diseases and tumors. Our existing pipeline consists of 10 monoclonal antibody drugs and 1See details»
Mabpharm Limitied
We have efficient R & D capabilities, extensive and advanced preparation technology and low-cost drug production capacity, with a view to provide high-quality and reasonably priced …See details»
泰州迈博太科药业有限公司 - 企查查
Mar 19, 2024 · 简介：泰州迈博太科药业有限公司是⼀家成⽴于2015年02月04日的有限责任公司，也是Mabpharm (HK) Limited旗下企业，属于以从事科学研究和技术服务业为主的企业。 位 …See details»
Mabpharm Limitied
TAIZHOU: Block G79, Lujia Road East and Koutai Road West, China Medical City, Taizhou, Jiangsu, PRC 225300; SHANGHAI: No. 301 Libing Road, Zhangjiang Hi-Tech Park, Pudong …See details»
迈博药业有限公司 - mabpharm.cn
我们三个核心产品中，CMAB008（英夫利西单抗）已在中国获批上市销售，CMAB007（奥马珠单抗）的新药上市申请已获中国国家药品监督管理局受理，CMAB009（西妥昔单抗）目前处 …See details»
Mabpharm Limitied
We have three core products, CMAB008 (infliximab) has been approved for marketing, the new drug application (NDA) of CMAB007 (omalizumab) has been accepted, and CMAB009 …See details»
Mabpharm Limitied
Based on new regulations and technical guidelines introduced by the NMPA on new biological drugs, we have also completed a head-to-head phase I comparative study against currently …See details»